Black Rock Inc. Aquestive Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AQST
# of Institutions
129Shares Held
44.5MCall Options Held
44.6KPut Options Held
182K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$31.2 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.07MShares$13 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.73MShares$11.9 Million0.45% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$5.41 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.53MShares$4.86 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $170M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...